Why taller people are smarter
29 August, 2013It hardly seems fair but people who are attractive because of one trait tend to have other attractive traits as well.
Familial DNA searches may misidentify family members
22 August, 2013Research published in the journal PLOS ONE, conducted by Rori Rohlfs and colleagues from the University of California at Berkeley and New York University, indicates that familial search methods may identify distant relatives as being closer to the perpetrator than they actually are.
Genes, male beauty and attractiveness to the other gender
19 August, 2013It’s a simple fact: some individuals are more attractive to the opposite sex than others. But what makes them more desirable?
SLIRP gene affects male fertility
19 August, 2013Researchers have found that the SLIRP gene - discovered at the Western Australian Institute for Medical Research (WAIMR) and known to affect hormone action in breast and prostate cancer cells - has an impact on male fertility.
Greiner Bio-One CELLrepellant Surface range
13 August, 2013 | Supplied by: Interpath Services Pty LtdThe Greiner Bio-One CELLrepellant Surface range is now available from Interpath Services. The surface technology effectively inhibits cell attachment.
Glue ear mystery comes unstuck
12 August, 2013Research from the University of Western Australia (UWA) could have a significant impact on the treatment of ear infections, reducing the need for antibiotics and surgery and tackling hearing loss in Indigenous communities.
Over 10,000 proteins in cancer cells identified
09 August, 2013Researchers at Technische Universität München (TUM) have decoded the proteome of 59 tumour cell lines from the US National Cancer Institute, known as the ‘NCI-60’ cell lines, which represent the most common tumour diseases in nine tissues (eg, brain, breast, bowels, skin, blood).
GE Healthcare MicroCal iTC200 biomolecular interaction measurement system
07 August, 2013 | Supplied by: Global Life Sciences SolutionsThe MicroCal iTC200 allows direct and label-free measurement of binding affinity and thermodynamic parameters from biomolecular interactions. All binding parameters (affinity, stoichiometry, enthalpy and entropy) are available in a single experiment.
GE Healthcare Biacore 4000 molecular interaction analysis system
07 August, 2013 | Supplied by: Global Life Sciences SolutionsThe Biacore 4000 offers a complete solution for large-scale, label-free molecular interaction analysis, delivering high throughput without compromising on data quality.
GE Healthcare Biacore T200 biomolecular interaction analysis system
06 August, 2013 | Supplied by: Global Life Sciences SolutionsThe Biacore T200 is a versatile, label-free system for detailed studies of biomolecular interactions, from early research to drug discovery and development and on to QC.
Why one person’s mutation kills when the same mutation in someone else is benign
02 August, 2013Scientists have begun to understand how the rest of the genome interacts with mutations, explaining why not everyone with identical genetic mutations develops a disease.
Bacteria invest in evolutionary success
02 August, 2013Researchers at Sydney and Exeter Universities have, for the first time, recreated and analysed the complex interplay between bacterial investment strategies and their outcomes.
GeneCopoeia Genome-TALER Human AAVS1 Safe Harbor Knock-in ORF Clones
31 July, 2013 | Supplied by: United Bioresearch Products Pty LtdGenome-TALER Human AAVS1 Safe Harbor Knock-in ORF Clones from GeneCopoeia are constructed for specifically transferring the ORF of interest from a donor plasmid into the AAVS1 safe harbour site in human chromosome 19 using the Genome-TALER Human AAVS1 Safe Harbor Gene Knock-in Kit.
Evolution is a group effort
29 July, 2013Researchers have found that rather than just one mutation causing enhanced survival, about five to seven mutations are required. These extra mutations are termed ‘genetic hitchhikers’ because they don’t appear to contribute to the enhanced fitness of the organism.
FDA permits marketing of TB bacteria and antibiotic-resistance test
26 July, 2013The US Food and Drug Administration (FDA) has authorised the marketing of the Xpert MTB/RIF assay, manufactured by Cepheid. This is the first FDA-reviewed test that can rapidly detect the bacteria that cause tuberculosis (TB) and determine if the bacteria contain genetic markers that make them resistant to rifampin, an important antibiotic for the treatment of TB.
